CHUGAI
Chugai futureproofs business through ‘user-buy-in’ adoption of E‑WorkBook. Introduction of E-WorkBook sees productivity gains of up...
Chugai futureproofs business through ‘user-buy-in’ adoption of E‑WorkBook. Introduction of E-WorkBook sees productivity gains of up...
Justin Gazard, Global Pharmacology & ADME Business Partner for Research Business Technology at Pfizer, talks to...
Early adoption of IDBS’ bioprocess platform puts Lonza Biologics ahead. Proactive use of IDBS’ E-WorkBook Suite...
Founded in 1863, Solvay is a global company focused on advanced materials and specialty chemicals, committed to developing...
Biokit futureproofs diagnostics business and maximizes R&D spend through introduction of E‑WorkBook. Since adopting E-WorkBook, Biokit...
Celera accelerates genetic marker research with IDBS, helping to identify coronary heart disease biomarkers. IDBS’ translational research...
IDBS and the University of Cambridge Join Forces for Cheminformatics Tools; Captures and Leverages IP with...
E-WorkBook: Bringing the electronic lab to biofuels and biochemicals production. Rapidly growing firm, BiCHEM ditches paper...
BASF selects IDBS to supply its enterprise R&D data management platform
Major European aerospace manufacturer, designing, developing and producing aircraft engines for both military and civilian use,...
Quarterly releases provide new product features and updates to customers with increased frequency. New releases and...
Genmab Uses ActivityBase XE to Analyze Results from its Discovery Activities, Accelerating Research into Cancer, Inflammatory...
Enterprise electronic data and knowledge management optimizes R&D cross functional collaboration at Nutricia Research. Within the...
Global biotech company transforms R&D process with electronic lab notebook. Data input, capture and search time...
Sealy Inc. improves efficiency and promotes corporate compliance with E-WorkBook, leading to significant productivity gains across...
Leading French biotech uses IDBS’ ActivityBase to optimize HTS and HCS. Inventiva has seen a tenfold...